In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965

Tubercle

Volumn 68, Issue 2, 1987, Pages 141-143

  Casal, M ^a   Gutierrez, J ^a   Gonzalez, J ^a   Ruiz, P ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE; NEW DRUG; ROXITHROMYCIN;

DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTIBIOTICS, ANTITUBERCULAR; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ISONIAZID; LEUCOMYCINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023213261     PISSN: 00413879     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-3879(87)90030-4     Document Type: Article

References (5)

1. In vitro comparison of the activity of RU-28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria
2. In vitro evaluation of the new macrolide antimicrobial agents RU28965, RU-29065 and RU-29702 and comparisons with other orally administered drugs
3. Procedures for the isolation and identification of mycobacteria
4. RU-28965, a new semisynthetic macrolide: preliminary pharmokinetic report